Patents Assigned to Guangzhou Realbenefitspot Pharmaceutical Co., Ltd.
  • Patent number: 11319529
    Abstract: This application pertains to methods of isolating virus particles and producing virus vaccine composition comprising subject a biological sample to an anion exchange chromatography and a hydroxyapatite chromatography. The application also pertains to rabies virus vaccine compositions and methods of assessing suitability of a virus vaccine composition or releasing a commercial batch of virus vaccine composition for clinical use.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: May 3, 2022
    Assignees: GUANGZHOU REALBENEFITSPOT PHARMACEUTICAL CO., LTD., GUANGZHOU YINHEYANGGUANG BIOLOGICS CO., LTD.
    Inventors: Dianlian Liu, Wen Ai, Mingfeng Shen
  • Patent number: 10260050
    Abstract: This application pertains to methods of isolating virus particles and producing virus vaccine composition comprising subject a biological sample to an anion exchange chromatography and a hydroxyapatite chromatography. The application also pertains to rabies virus vaccine compositions and methods of assessing suitability of a virus vaccine composition or releasing a commercial batch of virus vaccine composition for clinical use.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: April 16, 2019
    Assignee: Guangzhou Realbenefitspot Pharmaceutical Co., Ltd.
    Inventors: Dianlian Liu, Wen Ai, Mingfeng Shen